Ampio’s Covid-19 therapy proves safe in Phase I study,

US-based biopharmaceutical firm Ampio Pharmaceuticals has completed its Phase I clinical trial of intravenous (IV) Ampion treatment which …, US-based biopharmaceutical firm Ampio Pharmaceuticals has completed its Phase I clinical trial of intravenous (IV) Ampion treatment which …, Read More

Scroll to Top